Goodwin Procter LLP advised Pear Therapeutics on the deal. Pear Therapeutics announced its definitive business combination agreement with Thimble Point Acquisition Corp. (Nasdaq: THMA), a special purpose...
Pear Therapeutics’ $1.6 Billion Business Combination with Thimble Point Acquisition Corp.
Charlesbank Capital Partners’ Growth Investment in MB2 Dental
Goodwin Procter LLP advised Charlesbank Capital Partners on the deal. Charlesbank Capital Partners, a middle-market private investment firm, announced that an affiliated fund has made a significant...


























